The invention relates to devices that are stabilized at an intraluminal residence site in the gastrointestinal tract by their conformation, including dimensions of length and curvature. The device as a whole corresponds to the conformation of the residence site; more particularly, the curved or angled portions correspond to the curved or angled portions of the residence site and do not conform to an immediately proximal or distal site. In some embodiments, the conformationally stabilized device may effect a change in the residence site shape that contributes to stability of the device. Some embodiments are directed toward curbing appetite and/or reducing food intake, other embodiments may be directed toward other therapeutic ends. Some embodiments of the device are designed to reside wholly in the duodenum; others reside principally within the duodenum but extend proximally into the gastric antrum, while other embodiments are designed to reside elsewhere within the gastrointestinal tract.

A prosthetic attachment for a prosthetic limb. A base is attached to the prosthetic limb. The base has a magnet that is surrounded by base valleys and base peaks. An attachment piece is attached to the prosthetic attachment. The attachment piece also has a magnet that is surrounded by attachment piece valleys and attachment piece peaks. The magnetic force between the base magnet and the attachment piece magnet attracts the prosthetic attachment to the prosthetic limb so that the base peaks and valleys mates with the attachment piece peaks and valleys for a secure removable attachment. In a preferred embodiment a locking device is used to further secure the prosthetic attachment to the prosthetic limb. In a preferred embodiment the prosthetic attachment is a prosthetic hand and the prosthetic limb is a prosthetic arm.

An incontinence treatment system includes a urethral support extending between a first end and a second end, a first connector attached to the first end of the urethral support and a second connector attached to the second end of the urethral support, and an energy source. At least one of the first connector and the second connector is a cross-linked polymer connector having a glass transition temperature between 40-70 degrees Celsius. In this regard, the cross-linked polymer connector is stretched to provide a stretched cross-linked polymer connector having a product length. The energy source is adapted to provide energy from an extracorporeal location through intact skin to shorten the stretched cross-linked polymer connector to an implant length that is less than the product length.

A spinal distraction system, according to one aspect, includes an adjustable spinal distraction rod comprising first and second members, the adjustable spinal distraction rod configured for non-invasive elongation of the first and second members. The system includes an anchor rod configured for mounting to a bone of a subject, the anchor rod having one or more spring-biased tabs disposed at one end thereof, and a connector having first end and a second end, the first end having a receiving cup configured for detachable mounting on the anchor rod, wherein the one or more spring-biased tabs are configured to engage with an inner surface of the receiving cup, the connector having a second end operatively coupled to an end of a first member and wherein the second member is configured for mounting to a second bone of a subject.

A product for implantation within a soft tissue site of the human or animal body comprises a matrix of pulverized or morselized substantially non-mineralized native soft tissue (NSTM) of the human or animal body, provided in a therapeutic amount to induce growth of native tissue or organs and healing at the tissue site. The NSTM is composed of at least one soft tissue selected from the group consisting of cartilage, meniscus, intervertebral disc, ligament, tendon, muscle, fascia, periosteum, pericardium, perichondrium, skin, nerve, blood vessels, and heart valves or from organs such as bladder, lung, kidney, liver, pancreas, thyroid, or thymus. Preferably, the NSTM is composed of a soft tissue of the same type of tissue native to the repair site.

An intraocular lens system for implantation in an eye is provided. The intraocular lens system has a ciliary body implant with a ciliary magnet element, the ciliary body implant being implantable in the eye such that the ciliary magnet element at least partially follows the movements of the ciliary body of the eye. The intraocular lens system also includes an intraocular lens with a lens magnet element. The ciliary body implant and the intraocular lens are formed separately from each other and the intraocular lens system is adapted to control a refractive effect of the intraocular lens via an interaction between the ciliary magnet element and the lens magnet element in the eye. The disclosure also relates to a ciliary body implant and an intraocular lens.

A goggle lens is configured for use with a goggle frame having a frame body and a pair of frame engagement members positioned at respective lateral end portions of the frame body. The goggle lens includes a lens rim, and a lens element that is transparent to allow a user to view through the lens element. A pair of lens engagement members are coupled to respective lateral end portions of the lens rim. The pair of lens engagement members are selectively engageable with respective ones of the pair of frame engagement members. The pair of lens engagement members include a locking lens engagement member comprising a first element coupled to the lens rim, and a second element moveably coupled to the first element for facilitating selective engagement and disengagement with the respective one of the pair of frame engagement members.

An implantable fluid operated device may include a fluid reservoir configured to hold fluid, an inflatable member, and a pump assembly configured to transfer fluid between the fluid reservoir and the inflatable member. The pump assembly may include one or more fluid pumps and one or more valves. An electronic control system may control operation of the pump assembly based on fluid pressure measurements and/or fluid flow measurements received from the one or more sensing devices. The electronic control system may include an internal component installed with the implanted device, and an external component that is operable by a user to provide user input, and to receive output from the implanted device.

Provided is a treatment method and medical apparatus for preventing an object that becomes a causative agent causing pathogenesis of aspiration pneumonitis from invading a lung The treatment method includes a disposing step of disposing a first instrument, which allows the object that becomes a causative agent of aspiration pneumonitis to move from an esophagus to a stomach and suppresses movement of the object from the stomach to a larynx, in the esophagus and disposing a second instrument, which suppresses the object from invading the lung, in at least the larynx.

A system includes an adjustable implant configured for implantation internally within a subject and includes a permanent magnet configured for rotation about an axis of rotation, the permanent magnet operatively coupled to a drive transmission configured to alter a dimension of the adjustable implant. The system includes an external adjustment device configured for placement on or adjacent to the skin of the subject having at least one magnet configured for rotation, the external adjustment device further comprising a motor configured to rotate the at least one magnet and an encoder. Rotation of the at least one magnet of the external adjustment device effectuates rotational movement of the permanent magnet of the adjustable implant and alters the dimension of the adjustable implant. Drive control circuitry is configured to receive an input signal from the encoder.